Greywolf Therapeutics

0 followers

Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.​ We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presenta... Read more

Employees

11-50

Links


Org chart

Peter Joyce
Chief Executive Officer
Collapse
Andy Page
Chief Operating Officer/chief Business Officer
Tom Lillie
Chief Medical Officer
Paul Stainer
Vice President Operations, Transformation And Company Secretary
Jennifer Parsons
Finance Director
Jo Hume
Vp, Finance

Teams

This company has no teams yet